million people. To determine the price that it will pay for each drug, Medicaid uses the average private sector price. When Medicaid is a large part of the demand for a drug, this creates an incentive for its maker to increase prices for other health care consumers. Using drug utilization and expenditure data for the top 200 drugs in 1997 and in 2002, we investigate the relationship between the Medicaid market share (MMS) and the average price of a prescription. Our estimates imply that a 10 percentage-point increase in the MMS is associated with a 7 to 10 percent increase in the average price of a prescription. In addition, the Medicaid rules increase
Many U.S. employers have recently adopted less generous prescription drug benefits. In addition, in ...
A letter report issued by the Government Accountability Office with an abstract that begins "Prescri...
Correspondence issued by the Government Accountability Office with an abstract that begins "Prescrip...
In 2003 the federal-state Medicaid program provided prescription drug coverage to more than 50 milli...
erage to more than 50 million people. To determine the price that it will pay for each drug, Medicai...
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...
PURPOSE Prescription drug expenditures are the most rapidly growing component of total health care e...
This article examines Medicaid preferred drug lists (PDLs), a cost-containment tool that designates ...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...
This article examines Medicaid preferred drug lists (PDLs), a cost-containment tool that designates ...
This paper investigates prescription drug utilization changes following an exogenous shift in consum...
Generic drugs comprise an increasing share of total prescriptions dispensed in the U.S., rising from...
Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spendi...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...
Many U.S. employers have recently adopted less generous prescription drug benefits. In addition, in ...
A letter report issued by the Government Accountability Office with an abstract that begins "Prescri...
Correspondence issued by the Government Accountability Office with an abstract that begins "Prescrip...
In 2003 the federal-state Medicaid program provided prescription drug coverage to more than 50 milli...
erage to more than 50 million people. To determine the price that it will pay for each drug, Medicai...
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...
PURPOSE Prescription drug expenditures are the most rapidly growing component of total health care e...
This article examines Medicaid preferred drug lists (PDLs), a cost-containment tool that designates ...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...
This article examines Medicaid preferred drug lists (PDLs), a cost-containment tool that designates ...
This paper investigates prescription drug utilization changes following an exogenous shift in consum...
Generic drugs comprise an increasing share of total prescriptions dispensed in the U.S., rising from...
Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spendi...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...
Many U.S. employers have recently adopted less generous prescription drug benefits. In addition, in ...
A letter report issued by the Government Accountability Office with an abstract that begins "Prescri...
Correspondence issued by the Government Accountability Office with an abstract that begins "Prescrip...